Recruiting

PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine

Sponsor:

Labcorp Corporation of America Holdings, Inc

Code:

NCT05697198

Conditions

Lung Cancer

Ovarian Cancer

Uterine Cancer

Colorectal Cancer

Stomach Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

OmniSeq Test

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information